Old Web
English
Sign In
Acemap
>
authorDetail
>
Daniela Stokmaier
Daniela Stokmaier
University of Basel
Biochemistry
Asialoglycoprotein receptor
Chemistry
Multiple sclerosis
Ocrelizumab
4
Papers
264
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Author response: Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study
2021
Amit Bar-Or
Ann Herman
Daniela Stokmaier
Show All
Source
Cite
Save
Citations (0)
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study
2020
Neurology
Amit Bar-Or
Jonathan Calkwood
Cathy Chognot
Joanna Evershed
Edward J. Fox
Ann Herman
Marianna Manfrini
John McNamara
Derrick Robertson
Daniela Stokmaier
Jeanette Wendt
Kevin L. Winthrop
Anthony Traboulsee
Show All
Source
Cite
Save
Citations (132)
Design, synthesis and evaluation of monovalent ligands for the asialoglycoprotein receptor (ASGP-R)
2009
Bioorganic & Medicinal Chemistry
Daniela Stokmaier
Oleg Khorev
Brian Cutting
Rita Born
Daniel Ricklin
Thomas O.G. Ernst
Fabienne Böni
Kathrin Schwingruber
Martin Gentner
Matthias B. Wittwer
Morena Spreafico
Angelo Vedani
Said Rabbani
Oliver Schwardt
Beat Ernst
Show All
Source
Cite
Save
Citations (34)
Trivalent, Gal/GalNAc-containing ligands designed for the asialoglycoprotein receptor.
2008
Bioorganic & Medicinal Chemistry
Oleg Khorev
Daniela Stokmaier
Oliver Schwardt
Brian Cutting
Beat Ernst
Show All
Source
Cite
Save
Citations (98)
1